Search Within

Ross Levine

Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic characterization of secondary acute myeloid leukemia with mixed phenotype
    Meeting Abstract

    Galera, P.; Chan, A.; Derkach, A.; Liu, Y.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M. E.; Mata, D. A.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • DNMT3A mutations in the hematopoietic system promote colitis-associated colon cancer: A model of clonal hematopoiesis in solid tumors
    Meeting Abstract

    Feng, Y.; Newsome, R.; Robinson, T.; Bowman, R. L.; Zuniga, A.; Hall, K.; Bernsten, C.; Shabashvili, D.; Krajcik, K.; Gunaratne, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Entospletinib (ENTO) and decitabine (DEC) combination therapy in older newly diagnosed (ND) acute myeloid leukemia (AML) patients with mutant TP53 or complex karyotype is associated with poor response and survival: A phase 2 sub-study of the Beat AML Master Trial
    Meeting Abstract

    Duong, V. H.; Ruppert, A. S.; Mims, A. S.; Borate, U.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W. G.; Arellano, M. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Single cell ATAC lineage deconvolution reveals overlapping subclones in epigenetically distinct AML samples
    Meeting Abstract

    Dilip, D.; Koche, R.; Menghrajani, K.; Melnick, A.; Elemento, O.; Levine, R. L.; Glass, J. L.
    Blood (2021)

    Fulltext@MSK | Save
  • Multi-recombinase mouse models of FLT3-driven leukemia identifies distinct trajectories of mutational cooperativity and leukemic transformation
    Meeting Abstract

    Bowman, R. L.; Mishra, T.; Eisman, S. E.; Cai, L.; Xiao, W.; Waarts, M. R.; Sanchez Vela, P.; Fernández-Maestre, I.; Csete, I. S.; Potts, C. R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Germline RUNX1 mutations induce inflammation in hematopoietic stem and progenitor cells and predispose to hematologic malignancies
    Meeting Abstract

    Ahmad, M. H.; Hegde, M.; Wong, W. J.; Dunbar, A.; Carrascoso, A.; Garett, L. J.; Ferreira, N. K.; Liu, H.; Li, R.; Eberg, B. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Resistance to type II JAK2 inhibition in MPN is dependent on chromatin remodeling and MAPK activation and is targetable
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Stivala, S.; Brkic, S.; Yang, J. L.; Wicki, A.; Ghosh, N.; Passweg, J.; Dirnhofer, S.; Levine, R. L.; more...
    Swiss Medical Weekly (2021)

    Fulltext@MSK | Save
  • Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells
    Journal Article

    Chen, D.; Xia, S.; Zhang, R.; Li, Y.; Famulare, C. A.; Fan, H.; Wu, R.; Wang, M.; Zhu, A. C.; Elf, S. E.; more...
    Molecular Cell (2021)

    Fulltext@MSK | Save
  • Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy
    Journal Article

    Brkic, S.; Stivala, S.; Santopolo, A.; Szybinski, J.; Jungius, S.; Passweg, J. R.; Tsakiris, D.; Dirnhofer, S.; Hutter, G.; Leonards, K.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Clonal hematopoiesis is associated with risk of severe COVID-19
    Journal Article

    Bolton, K. L.; Koh, Y.; Foote, M. B.; Im, H.; Jee, J.; Sun, C. H.; Safonov, A.; Ptashkin, R.; Moon, J. H.; Lee, J. Y.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save